Article

B&L Foundation funds $2.5M engineering chair

Rochester, NY—The Bausch & Lomb Foundation has donated $2.5 million to the Rochester Institute of Technology (RIT) to fund the Bausch & Lomb Endowed Chair in Microsystems Engineering in the institute's Kate Gleason College of Engineering.

Rochester, NY-The Bausch & Lomb Foundation has donated $2.5 million to the Rochester Institute of Technology (RIT) to fund the Bausch & Lomb Endowed Chair in Microsystems Engineering in the institute's Kate Gleason College of Engineering.

Several research programs being jointly developed by Bausch & Lomb and RIT could involve additional funding of $2.5 million over the next 5 years. The research will delve into potential therapeutic and diagnostic technology to address ocular diseases and conditions. Projects being considered include advanced microsystems and technologies to diagnose, monitor, and treat eye disease; the development of biodegradable devices for sustained drug delivery to the eye; and accommodating IOLs to provide presbyopic vision correction for patients with cataracts.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.